Clinical Trials

300 enrolled

Breast Neoplasms, Neoplasm Metastasis

NCT04307277 2026-04-14

CHIC-STS01

600 enrolled

Sarcoma

NCT06731478 2026-03-16

Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer

726 enrolled

Stomach Neoplasms

NCT04575935 2026-03-05

Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE Trial

580 enrolled

Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT07022483 2026-02-04

Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer

710 enrolled

Gynecologic

Neoplasms, Endometrial Neoplasms

NCT06627712 2026-01-30

SBRT Combined With PD-1 Inhibitor and Chemotherapy in Early-stage TNBC

318 enrolled

Triple Negative Breast Neoplasms

NCT05909332 2026-01-21

Study of Antivascular Therapy Combined With Chemotherapy Versus Chemotherapy in Adjuvant Therapy of TNBC-BLIS Patients (BCTOP-T-A03)

764 enrolled

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT03875781 2026-01-15

NORAD01

540 enrolled

Rectal Neoplasms

NCT06899126 2026-01-08

DESTINY-Lung06

686 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05717166 2025-12-31

SABR-SYNC

180 enrolled

Tumor-Agnostic

Neoplasm Metastasis

NCT06840782 2025-09-15

OliGRAIL

124 enrolled

Oligometastatic Non-small Cell Lung Cancer (NSCLC)

NCT07062263 2025-07-14

TAB-2

220 enrolled

Biliary Tract Neoplasms

NCT06228079 2025-07-04

Adjuvant vs Surgery Only in Early-stage Recurrent NPC

176 enrolled

Nasopharyngeal Carcinoma

NCT07020247 2025-06-13

Personalized Long-course Radiotherapy Plus Chemotherapy With or Without Immunotherapy for LARC: PALACE Study

184 enrolled

Locally Advanced Rectal Cancer (LARC)

NCT07016126 2025-06-11

D-BACE in Combination With Chemotherapy and Carelizumab for Resectable II-IIIA or Potentially Resectable T3-4N2 Stage IIIB NSCLC

70 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06913777 2025-06-06

Neoadjuvant SNF Precision Therapy Phase III

404 enrolled

Neoadjuvant Therapy

NCT06598527 2025-05-29

SACTION2401

360 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT06794086 2025-05-13

SPARKLE-L

24 enrolled

Colorectal Neoplasms

NCT06196736 2025-04-13

A Study to Evaluate 9MW2821 Versus Chemotherapy in Subjects With Previously Treated Locally Advanced or Metastatic Urothelial Cancer

432 enrolled

Genitourinary

Advanced Urothelial Carcinoma

NCT06692166 2024-11-22

A Study to Evaluate 9MW2821 Versus Treatment of Physician's Choice for Subjects With Recurrent or Metastatic Cervical Cancer

420 enrolled

Gynecologic

Uterine Cervical Diseases, Uterine Cervical Neoplasms, Genital Neoplasms, Female, Neoplasms, Neoplasms by Site, Urogenital Neoplasms, Uterine Diseases, Uterine Neoplasms

NCT04747054 2024-10-26

PembroMetaRT

102 enrolled

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Carcinoma, Squamous Cell, Neoplasm Metastasis

NCT06566755 2024-08-22

Cadonilimab (AK104) Combined With Chemotherapy and Bevacizumab as First-line Treatment for RAS Mutated or Right Sided-metastatic MSS Colorectal Cancer

30 enrolled

Colorectal Neoplasms

NCT06516133 2024-07-23

OART

494 enrolled

Nasopharyngeal Carcinoma

NCT06086457 2024-07-16

PD-1 Inhibitor Plus Chemotherapy With or Without Radiotherapy in Patients With Metastatic Esophageal Cancer

436 enrolled

Esophageal Neoplasms

NCT06341621 2024-04-10

Rainbow

1,900 enrolled

Breast Neoplasms

NCT06350825 2024-04-05

Cytoreductive Prostatectomy Combined With Triple or Dual Systemic Therapy in mHSPC Patients

200 enrolled

Genitourinary

Prostatic Neoplasms, Directly Observed Therapy

NCT05999149 2024-02-21

BCTOP-T-N01

424 enrolled

Triple Negative Breast Neoplasms

NCT05145660 2022-09-27

Optimization of Cervical Nodal CTV for Early and Medium Stage NPC

414 enrolled

Nasopharyngeal Carcinoma

NCT02535221 2021-11-29

Neoadjuvant Endocrine Therapy Versus Chemotherapy in Premenopausal Patients With ER+ & HER2- Breast Cancer

234 enrolled

Breast Neoplasms

NCT04997837 2021-08-10

Study of Adjuvant Chemotherapy With or Without PD-1 Inhibitors and Chemoradiotherapy in Resected pN3 Gastric (G) or GEJ Adenocarcinoma

433 enrolled

Stomach Neoplasms

NCT04288999 2020-06-04

JCOG1801

110 enrolled